Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data. [electronic resource]
Producer: 20190911Description: 1840-1853 p. digitalISSN:- 2219-2840
- Adaptor Proteins, Signal Transducing -- metabolism
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Autophagy
- Beclin-1 -- metabolism
- Biomarkers, Tumor -- metabolism
- Cell Cycle Proteins
- Cetuximab -- pharmacology
- Colorectal Neoplasms -- drug therapy
- Down-Regulation
- Drug Resistance, Neoplasm
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Male
- Microtubule-Associated Proteins -- metabolism
- Middle Aged
- Neoplasm Staging
- Phosphoproteins -- metabolism
- Prognosis
- Progression-Free Survival
- Proto-Oncogene Proteins p21(ras) -- genetics
- Up-Regulation
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.